Sort
82,697 grants matching “vaccine development”
Clinical Interventional Studies of HIV Reservoirs
$1,530,173Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
mVACS--mRNA Vaccines for C. difficile Suppression
$1,529,954Frederic D Bushman · University Of Pennsylvania · U19 · FY2024 · AI
mVACS--mRNA Vaccines for C. difficile Suppression
$1,529,954Frederic D Bushman · University Of Pennsylvania · U19 · FY2023 · AI
mVACS--mRNA Vaccines for C. difficile Suppression
$1,529,954Frederic D Bushman · University Of Pennsylvania · U19 · FY2025 · AI
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$1,529,800Mark M Davis · Stanford University · U19 · FY2009 · AI
Vaccine development and production
$1,529,201Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2022 · AI
Initial clinical evaluation of attenuated Shigella flexneri 2a live vector expressing enterotoxigenic Escherichia coli antigens, strain CVD 1208S-122.
$1,529,187Wilbur H. Chen · University Of Maryland Baltimore · U01 · FY2021 · AI
Natural History of HPV Infection to Neoplasia
$1,528,615Anna-Barbara None Moscicki · University Of California, San Francisco · R37 · FY2012 · CA
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,528,540John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2018 · AI
Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research
$1,528,493Michael K Axthelm · Oregon Health & Science University · U42 · FY2017 · OD
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors
$1,528,431Alan Thomas Johnson · Hawaii Biotech, Inc. · R01 · FY2014 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$1,528,344Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2023 · AI
Influenza and Emerging Infectious Diseases
$1,528,179Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,528,062Judd E Shellito · Lsu Health Sciences Center · P01 · FY2006 · HL
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK
$1,527,881University Of Alabama At Birmingham · U01 · FY2003 · HD
Core D: Nonhuman Primates
$1,527,673Francois J Villinger · University Of Washington · P01 · FY2022 · AI
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,527,632Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
ETIB Clinical Research Core
$1,527,560Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2016 · CA
Malaria Vaccine: BSAM
$1,527,381Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
NIAID- VRC- Evaluating mRNA Vaccine Candidates and Capability Development
$1,527,328Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine
$1,526,960Mary E. Klotman · Duke University · P01 · FY2019 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,526,515Judd E Shellito · Lsu Health Sciences Center · P01 · FY2007 · HL
Clinical Program in Pediatric Sarcomas
$1,526,231Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immune correlates of protection
$1,526,197Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Ohio State University AIDS Clinical Trials Unit
$1,526,113Susan L Koletar · Ohio State University · U01 · FY2011 · AI